Concepedia

Rowena DeJesus

RD

6

Publications

812

Citations

6

H-Index

2016

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Harvard University

Massachusetts General Hospital

Sana Biotechnology (United States)

Rowena DeJesus is an author at Novartis (Switzerland) specializing in medicine, cell biology, and gene editing.

Top concepts

Publications per year

2016–2023

6

Publications

6

Autophagy-Independent Lysosomal Targeting Regulated by ULK1/2-FIP200 and ATG9

Jonathan M. Goodwin, William E. Dowdle, Rowena DeJesus et al. · Cell Reports · 2017 · 184 citations · Full text

<scp>TMEM</scp> 41B is a novel regulator of autophagy and lipid mobilization

Francesca Moretti, Phil Bergman, Stacie E. Dodgson et al. · EMBO Reports · 2018 · 171 citations · Full text

, , +9

Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62

Rowena DeJesus, Francesca Moretti, Gregory McAllister et al. · eLife · 2016 · 152 citations · Full text

, , +16

Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques

Xiaomeng Hu, Kathy White, Ari G. Olroyd et al. · Nature Biotechnology · 2023 · 131 citations · Full text

Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagy

Christoph Potting, Christophe Crochemore, Francesca Moretti et al. · Proceedings of the National Academy of Sciences · 2017 · 97 citations · Full text

Rows per page

1–5 of 6